Citigroup’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16K | Sell |
6,906
-3,214
| -32% | -$7.42K | ﹤0.01% | 4390 |
|
|
2025
Q1 | $79K | Sell |
10,120
-711
| -7% | -$5.55K | ﹤0.01% | 3953 |
|
|
2024
Q4 | $50.6K | Buy |
10,831
+1,074
| +11% | +$5.02K | ﹤0.01% | 4237 |
|
|
2024
Q3 | $52.6K | Buy |
9,757
+7,101
| +267% | +$38.3K | ﹤0.01% | 4231 |
|
|
2024
Q2 | $23.4K | Sell |
2,656
-45,388
| -94% | -$400K | ﹤0.01% | 4217 |
|
|
2024
Q1 | $565K | Buy |
48,044
+12,144
| +34% | +$143K | ﹤0.01% | 2772 |
|
|
2023
Q4 | $404K | Buy |
+35,900
| New | +$404K | ﹤0.01% | 2839 |
|
|
2022
Q3 | – | Sell |
-1,300
| Closed | -$11K | – | 5181 |
|
|
2022
Q2 | $11K | Buy |
+1,300
| New | +$11K | ﹤0.01% | 4594 |
|
|
2021
Q2 | – | Sell |
-1,908
| Closed | -$23K | – | 5529 |
|
|
2021
Q1 | $23K | Buy |
+1,908
| New | +$23K | ﹤0.01% | 4504 |
|